These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23393396)

  • 1. Long-term use of lipid-lowering drugs slows progression of carotid atherosclerosis: the Tromso study 1994 to 2008.
    Herder M; Arntzen KA; Johnsen SH; Eggen AE; Mathiesen EB
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):858-62. PubMed ID: 23393396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for progression of carotid intima-media thickness and total plaque area: a 13-year follow-up study: the Tromsø Study.
    Herder M; Johnsen SH; Arntzen KA; Mathiesen EB
    Stroke; 2012 Jul; 43(7):1818-23. PubMed ID: 22550052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic syndrome and progression of carotid atherosclerosis over 13 years. The Tromsø study.
    Herder M; Arntzen KA; Johnsen SH; Mathiesen EB
    Cardiovasc Diabetol; 2012 Jun; 11():77. PubMed ID: 22738646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carotid atherosclerosis predicts future myocardial infarction but not venous thromboembolism: the Tromso study.
    Hald EM; Lijfering WM; Mathiesen EB; Johnsen SH; Løchen ML; Njølstad I; Wilsgaard T; Rosendaal FR; Brækkan SK; Hansen JB
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):226-30. PubMed ID: 24177328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein in atherosclerosis - A risk marker but not a causal factor? A 13-year population-based longitudinal study: The Tromsø study.
    Eltoft A; Arntzen KA; Hansen JB; Wilsgaard T; Mathiesen EB; Johnsen SH
    Atherosclerosis; 2017 Aug; 263():293-300. PubMed ID: 28728065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lp(a) (Lipoprotein(a)) Levels Predict Progression of Carotid Atherosclerosis in Subjects With Atherosclerotic Cardiovascular Disease on Intensive Lipid Therapy: An Analysis of the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) Carotid Magnetic Resonance Imaging Substudy-Brief Report.
    Hippe DS; Phan BAP; Sun J; Isquith DA; O'Brien KD; Crouse JR; Anderson T; Huston J; Marcovina SM; Hatsukami TS; Yuan C; Zhao XQ
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):673-678. PubMed ID: 29301785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 persons: the Tromsø Study.
    Johnsen SH; Mathiesen EB; Joakimsen O; Stensland E; Wilsgaard T; Løchen ML; Njølstad I; Arnesen E
    Stroke; 2007 Nov; 38(11):2873-80. PubMed ID: 17901390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines in HIV-Infected Adults With Carotid Atherosclerosis.
    Phan BAP; Weigel B; Ma Y; Scherzer R; Li D; Hur S; Kalapus SC; Deeks S; Hsue P
    Circ Cardiovasc Imaging; 2017 Jul; 10(7):e005995. PubMed ID: 28674084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Subclinical Atheromatosis Progression over 2 Years in Patients with Different Stages of CKD.
    Gracia M; Betriu À; Martínez-Alonso M; Arroyo D; Abajo M; Fernández E; Valdivielso JM;
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):287-96. PubMed ID: 26668022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating estradiol is an independent predictor of progression of carotid artery intima-media thickness in middle-aged men.
    Tivesten A; Hulthe J; Wallenfeldt K; Wikstrand J; Ohlsson C; Fagerberg B
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4433-7. PubMed ID: 16940451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for the progression of carotid intima-media thickness over a 16-year follow-up period: the Malmö Diet and Cancer Study.
    Rosvall M; Persson M; Östling G; Nilsson PM; Melander O; Hedblad B; Engström G
    Atherosclerosis; 2015 Apr; 239(2):615-21. PubMed ID: 25746169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carotid plaque, intima-media thickness, and incident aortic stenosis: a prospective cohort study.
    Martinsson A; Östling G; Persson M; Sundquist K; Andersson C; Melander O; Engström G; Hedblad B; Smith JG
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2343-8. PubMed ID: 25231637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population distribution of traditional and the emerging cardiovascular risk factors carotid plaque and IMT: the REFINE-Reykjavik study with comparison with the Tromsø study.
    Thorsson B; Eiriksdottir G; Sigurdsson S; Gudmundsson EF; Bots ML; Aspelund T; Arntzen KA; Mathiesen EB; Gudnason V
    BMJ Open; 2018 May; 8(5):e019385. PubMed ID: 29858406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 is an independent predictor of progressive atherosclerosis in the carotid artery: The Tromsø Study.
    Eltoft A; Arntzen KA; Wilsgaard T; Mathiesen EB; Johnsen SH
    Atherosclerosis; 2018 Apr; 271():1-8. PubMed ID: 29453087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated high-density lipoprotein cholesterol levels are protective against plaque progression: a follow-up study of 1952 persons with carotid atherosclerosis the Tromsø study.
    Johnsen SH; Mathiesen EB; Fosse E; Joakimsen O; Stensland-Bugge E; Njølstad I; Arnesen E
    Circulation; 2005 Jul; 112(4):498-504. PubMed ID: 16027250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carotid atherosclerosis predicts lower cognitive test results: a 7-year follow-up study of 4,371 stroke-free subjects - the Tromsø study.
    Arntzen KA; Schirmer H; Johnsen SH; Wilsgaard T; Mathiesen EB
    Cerebrovasc Dis; 2012; 33(2):159-65. PubMed ID: 22222422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage study.
    Sillesen H; Muntendam P; Adourian A; Entrekin R; Garcia M; Falk E; Fuster V
    JACC Cardiovasc Imaging; 2012 Jul; 5(7):681-9. PubMed ID: 22789936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red cell distribution width and carotid atherosclerosis progression. The Tromsø Study.
    Lappegård J; Ellingsen TS; Vik A; Skjelbakken T; Brox J; Mathiesen EB; Johnsen SH; Brækkan SK; Hansen JB
    Thromb Haemost; 2015 Mar; 113(3):649-54. PubMed ID: 25631329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of smoking on carotid intima-media thickness progression rate and rate of lumen diameter reduction.
    Hansen K; Östling G; Persson M; Nilsson PM; Melander O; Engström G; Hedblad B; Rosvall M
    Eur J Intern Med; 2016 Mar; 28():74-9. PubMed ID: 26548715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High titer of anti-citrullinated peptide antibody is a risk factor for severe carotid atherosclerotic plaque in patients with rheumatoid arthritis: the TOMORROW study.
    Okano T; Inui K; Sugioka Y; Sugioka K; Matsumura Y; Takahashi S; Tada M; Mamoto K; Wakitani S; Koike T; Nakamura H
    Int J Rheum Dis; 2017 Aug; 20(8):949-959. PubMed ID: 28627096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.